Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05713695 · ClinicalTrials.gov registry record · NA
Supporting Treatment Access and Recovery Through Linkage and Support
A NA study of Substance Use Disorders and Mental Health Disorders, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT05713695: Recruiting NA study of Substance Use Disorders and Mental Health Disorders, sponsored by University of Massachusetts, Worcester.
NCT05713695 is a NA study of Substance Use Disorders and Mental Health Disorders that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 208 participants, below the 498-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05713695, a NA study of Substance Use Disorders and Mental Health Disorders, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
This 3-year Hybrid Type 1 study will randomize 208 people with co-occurring substance use and mental health disorders (COD) referred from the Worcester Hub. This study seeks to evaluate the effectiveness of MISSION, a multi-component team approach, versus linkage with a Peer Specialist on improving outcomes among individuals with CODs. We expect that individuals receiving MISSION versus linkage only will show greater improvement in treatment engagement, substance use, and mental health outcomes. This study will also concurrently conduct a process evaluation to inform sustainability and future implementation of such interventions.
Primary Outcome
Measured by self-report days of use using the Time-line Follow Back (TLFB)
Conditions Studied
Interventions
- BEHAVIORAL Full MISSION
- BEHAVIORAL Linkage Only Delivered by a Peer Specialist
Study Locations (1)
Massachusetts
- University of Massachusetts Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2023-05-24 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT05713695 shows while recruiting
NCT05713695 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Full MISSION is the first listed.
NCT05713695 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05713695 about?
NCT05713695 is a clinical study titled "Supporting Treatment Access and Recovery Through Linkage and Support". This 3-year Hybrid Type 1 study will randomize 208 people with co-occurring substance use and mental health disorders (COD) referred from the Worcester Hub. This study seeks to evaluate the effectiveness of MISSION, a multi-component team approach, versus linkage with a Peer Specialist on improving ...
What is the current status of trial NCT05713695?
This trial is currently recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2023-05-24. Estimated completion is 2026-09.
What conditions does trial NCT05713695 study?
This clinical trial studies the following conditions: Substance Use Disorders, Mental Health Disorders.
What interventions are being tested in trial NCT05713695?
The interventions under investigation include: Full MISSION (BEHAVIORAL), Linkage Only Delivered by a Peer Specialist (BEHAVIORAL).
Who is sponsoring clinical trial NCT05713695?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05713695 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05713695's enrollment target sits among peer trials
208 32nd of 93 higher than 61 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
-
The Oklahoma Parent-Child Assistance Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI